Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:othertreatments:salvestrols [08.30.2009] kenchome:othertreatments:salvestrols [10.20.2016] – [Curative treatments must generate immunopathology] sallieq
Line 1: Line 1:
 +====== Salvestrols    ====== 
  
 +Salvestrols are a new class of natural anticancer chemicals, which are found in plants and safely eaten in the diet. Initially non-toxic to the body’s normal cells, Salvestrols become activated inside human cancer cells by an enzyme, CYP1B1 (pronounced “sip one bee one”). The activated Salvestrols then cause the cancer cells to stop growing or die, without harming normal cells. This specificity of action is possible because CYP1B1 is an intrinsic component of cancer cells and occurs in all of the wide range of different types of cancer that have been studied to date, but is absent from normal cells.
 +
 +
 +===== Antibiotics that are okay under special circumstances =====
 +
 +
 +
 +===== Curative treatments must generate immunopathology =====
 +
 +<html><div class="mainarticle">Main section:</html> [[home:protocol:olmesartan#vitamin_d_receptor_agonist|Vitamin D Receptor agonist]]
 +
 +According to the Marshall Pathogenesis, patients must generate immunopathology in order to recover from chronic inflammatory disease. To this end, regular dosing of olmesartan (Benicar) is critical. Olmesartan's action as a VDR agonist allows Marshall Protocol patients to activate their innate immune response. This is evident in patients taking MP antibiotics who do not begin killing bacteria until they take olmesartan.
 +
 +
 +
 +{{tag>non-MP_therapies}}
 +
 +===== Notes and comments =====
 +GETCONTENT
 +
 +
 +
 +
 +  * Legacy content
 +    * none
 +    * this is a 'test' topic for consideration of the value of it's contents
 +
 +
 +===== References =====
home/othertreatments/salvestrols.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.